(Total Views: 603)
Posted On: 08/04/2020 4:39:00 PM
Post# of 145247
Are we going to skip results from CD10 with the positive safety data/decreased SAEs and significant results of Day 3 smyotonic and decrease in NEWS scores at 3,7&14?
Much as I would like the bump I’m price expected from uplisting, results are what will drive EUA and the approval.
Much as I would like the bump I’m price expected from uplisting, results are what will drive EUA and the approval.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)